Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review
about
Progress in corneal wound healingAdenovirus-driven overexpression of proteinases in organ-cultured normal human corneas leads to diabetic-like changesNormalization of wound healing and diabetic markers in organ cultured human diabetic corneas by adenoviral delivery of c-Met geneWounding the cornea to learn how it heals.Alterations of epithelial stem cell marker patterns in human diabetic corneas and effects of c-met gene therapySynergistic effect of methionine encephalin (MENK) combined with pidotimod(PTD) on the maturation of murine dendritic cells (DCs)Intranasal delivery of nanomicelle curcumin promotes corneal epithelial wound healing in streptozotocin-induced diabetic miceA systematic review on the impact of diabetes mellitus on the ocular surface.New therapeutic approaches in the treatment of diabetic keratopathy: a review.Opioid system and Alzheimer's disease.Age-related cataract and drug therapy: opportunities and challenges for topical antioxidant delivery to the lens.Diabetic complications in the cornea.Differential regulation of GLUT1 activity in human corneal limbal epithelial cells and fibroblasts.Effect of stem cell therapy on induced diabetic keratopathy in albino rat.Aloe vera gel facilitates re-epithelialization of corneal alkali burn in normal and diabetic rats.Effect of topical naltrexone 0.3% on corneal sensitivity and tear parameters in normal brachycephalic dogs.Determination of Risk Factors and Treatment of Dry Eye Disease in Type 1 Diabetes Before Corneal Complications at Sindh Institute of Ophthalmology And Visual Sciences.Evaluation of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer nanomicelle for trigeminal ganglion neurons delivering with intranasal administration.
P2860
Q28081311-A5934BF9-DF3E-49A2-B0BE-15905B47C97DQ33625853-64340952-FB52-4B4F-88DD-9FA60018613FQ33755962-A443CAB9-8983-44D8-8B95-2E2DB97D81D2Q33811160-9F40EF3C-2362-42A0-81BB-93B1AA76402CQ35175327-86AD9436-5DB1-4E53-B8AB-B5F7EA94E3BFQ37521866-DAB3013A-B997-493C-8E77-CC77464A3B97Q37736249-EFE726B1-59E9-4771-BCD4-1439DF8816F3Q37737782-C8DE51E3-3B8D-48F9-9F00-1DE6313B963AQ37802919-693667DE-E8A7-4688-B4B5-68A6EB699F2BQ38004941-517C4C59-7901-4DC5-BA07-E88A1E06FCE3Q38341268-7277BE47-5FC5-4D85-A877-EE0DB92AF307Q39238815-016612EF-AE00-4B4E-AAAD-8499E0DCA9EFQ39272087-8DB1820B-5825-4772-94A6-BF9BDFBEF73BQ42867737-FFD2B6C3-019E-45F4-894B-39696C1B1F36Q43192113-44F5011E-F6BA-4EDE-9B2E-37BB530E3821Q46773661-767C35F3-8C94-441D-93BB-A0F18B493254Q47141449-1980AE18-A1C2-4B43-8D50-F10664560D59Q47342211-B424EB19-30E9-4685-BFA0-DA665409194D
P2860
Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Diabetic keratopathy and treat ...... axis with naltrexone: a review
@ast
Diabetic keratopathy and treat ...... axis with naltrexone: a review
@en
type
label
Diabetic keratopathy and treat ...... axis with naltrexone: a review
@ast
Diabetic keratopathy and treat ...... axis with naltrexone: a review
@en
prefLabel
Diabetic keratopathy and treat ...... axis with naltrexone: a review
@ast
Diabetic keratopathy and treat ...... axis with naltrexone: a review
@en
P2093
P2860
P921
P1476
Diabetic keratopathy and treat ...... axis with naltrexone: a review
@en
P2093
Ian S Zagon
Joseph W Sassani
Matthew S Klocek
Patricia J McLaughlin
P2860
P304
P356
10.1016/J.BRAINRESBULL.2009.08.008
P577
2009-08-14T00:00:00Z